LARRY ALLEN: Open Payments
NPI 1942660287 · SHREVEPORT, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,491 in 59 payments from 9 companies in 2025. Trend: 2023 $965 · 2024 $1,304 · 2025 $1,491
Food & beverage: $1,473Education: $18
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 27 | $472 |
| Axsome Therapeutics, Inc. | 12 | $452 |
| E.R. Squibb & Sons, L.L.C. | 4 | $155 |
| Janssen Pharmaceuticals, Inc | 4 | $104 |
| Lundbeck LLC | 5 | $102 |
| Boston Scientific Corporation | 1 | $81 |
| Alkermes, Inc. | 3 | $57 |
| Vanda Pharmaceuticals Inc. | 2 | $49 |
| Collegium Pharmaceutical, Inc. | 1 | $20 |
Products named: VRAYLAR, Auvelity, COBENFY, INVEGA SUSTENNA, REXULTI, General - Hemostasis, ARISTADA, FANAPT.
Industry payments across LA — which companies pay providers there.
